Atlas Trials

Metabotropic Glutamate Receptor-5 (mGlur5) Effects on Reward-Related fMRI-BOLD Activation in FHP and FHN

Clinical trial NCT03341715 · COMPLETED

Trial details

NCT number
NCT03341715
Sponsor
Yale University
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Familial Alcoholism Vulnerability
Start date
2018-06-01
Primary completion
2019-11-13
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.